Patent US4583800A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4599197A Expired / Lapsed US ⏱️ 0.0 years remaining

Purification and activity assurance of precipitated heterologous proteins

Assignee: Genentech Inc
•
Filing: 1984-06-01
•
Granted: 1986-07-08
•
Expires: 2004-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A heterologous expression product in host cells is separated from the host cell material by suspending the material in a buffered solution, disrupting the cells and separating the product as refractile material. The refractile material can be dissolved in a strongly denaturing solution, which is then weakened while keeping the protein in solution, thereby allowing unfolding and refolding of the protein.

Inventors

  • 👤 Ronald B. Wetzel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 23:18
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6478; C12N9/6481; C07; C07K; C07K1/00; C07K1/107; C07K1/113; C07K1/1133; C12N9/6424; C12N9/6456; C12N9/6462; C12Y; C12Y304/00; C12Y304/21; C12Y304/21073; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/948; Y10S530/00; Y10S530/82; Y10S530/825

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 77 words
A process for re-activating proteins formed as refractile bodies in host cells, said proteins not subjected to CNBR treatment which process comprises: (a) converting said proteins not subjected to CNBR treatment and dissolved in a strongly denaturing solution to the corresponding protein-S-sulfonate; (b) converting the strongly denaturing solution to a weakly denaturing solution in which the protein-S-sulfonate remains dissolved; and (c) treating the resulting protein-S-sulfonate with a sulfhydryl containing moiety containing a small percentage of its disulfide.
Claim 2
Dependent Claim 77 words
A process for re-activating proteins formed as refractile bodies in host cells, said proteins not subjected to CNBR treatment which process comprises: (a) converting said proteins not subjected to CNBR treatment and dissolved in a strongly denaturing solution to the corresponding protein-S-sulfonate; (b) converting the strongly denaturing solution to a weakly denaturing solution in which the protein-S-sulfonate remains dissolved; and (c) treating the resulting protein-S-sulfonate with a sulfhydryl containing moiety containing a small percentage of its disulfide.
Claim 3
Dependent Claim 14 words
The process of claim 1 wherein the weakly denaturing solution is 1-9M in urea.
Claim 4
Dependent Claim 36 words
The process of claim 1 wherein the strongly denaturing solution is 4 to 9M in a guanidine salt, and the weakly denaturing solution is 1 to 9M in urea or 0.5 to 2M in guanidine hydrochloride.
Claim 5
Dependent Claim 13 words
The process of claim 1 wherein the sulfhydryl containing moiety is reduced glutathione.
Claim 6
Dependent Claim 31 words
The process of claim 4 whwerein the dissolved protein is converted to the protein-S-sulfonate in (a) by treating the solution with a mixture of a sulfite and a weak oxidizing agent.
Claim 7
Dependent Claim 19 words
The process of claim 1 wherein the sulfite is sodium sulfite and the weak oxidizing agent is sodium tetrathionate.
Claim 8
Dependent Claim 98 words
A process for re-activating heterologous proteins formed as refractile bodies in host cells said proteins not subjected to CNBR treatment which process comprises: (a) converting said proteins not subjected to CNBR treatment and dissolved in a strongly denaturing solution to the corresponding protein-S-sulfonate; (b) replacing the strongly denaturing solution with a weakly denaturing solution; (c) subjecting the dissolved protein-S-sulfonate to one or more purification procedures selected from the group consisting of ion exchange chromatography and gel permeation chromatography; and (d) treating the purified protein-S-sulfonate from (c) with a sulfhydryl reagent containing a small percentage of its disulfide form.
Claim 9
Dependent Claim 98 words
A process for re-activating heterologous proteins formed as refractile bodies in host cells said proteins not subjected to CNBR treatment which process comprises: (a) converting said proteins not subjected to CNBR treatment and dissolved in a strongly denaturing solution to the corresponding protein-S-sulfonate; (b) replacing the strongly denaturing solution with a weakly denaturing solution; (c) subjecting the dissolved protein-S-sulfonate to one or more purification procedures selected from the group consisting of ion exchange chromatography and gel permeation chromatography; and (d) treating the purified protein-S-sulfonate from (c) with a sulfhydryl reagent containing a small percentage of its disulfide form.
Claim 10
Dependent Claim 36 words
The process of claim 7 wherein the strongly denaturing solution is 4 to 9M in a guanidine salt and the weakly denaturing solution is 1 to 9M in urea or 0.5 to 2M in guanidine hydrochloride.
Claim 11
Dependent Claim 30 words
The process of claim 7 wherein the dissolved protein is converted to the protein-S-sulfonate in step (a) by treating the solution with a mixture of sulfite and weak oxidizing agent.
Claim 12
Dependent Claim 16 words
The process of claim 7 which includes carrying out a gel permeation chromatography step in (c).
Claim 13
Dependent Claim 15 words
The process of claim 7 which includes carrying out ion exchange chromatography in step (c).
Claim 14
Dependent Claim 19 words
The method of claim 7 wherein the purification procedure includes the use of ion exchange chromatography comprising DEAE cellulose.
Claim 15
Dependent Claim 20 words
The method of claim 12 wherein the DEAE cellulose absorbs contaminants of the heterologous protein, but not the heterologous protein.
Claim 16
Dependent Claim 8 words
Protein reactivated by the process of claim 1.
Claim 17
Dependent Claim 8 words
Protein reactivated by the process of claim 7.
Claim 18
Dependent Claim 13 words
The process of claim 1 including removing any remaining denaturant from the solution.
Claim 19
Dependent Claim 13 words
The process of claim 7 including removing substantially all of the remaining denaturant.

References Cited (Backward Citations)

EP0048970A2 Cited
US4414150A Cited
EP0068693A2 Cited
EP0068691A2 Cited
EP0075444B1 Cited
EP0077670A2 Cited
EP0089233A2 Cited
WO1983004418A1 Cited
EP0122080A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-07-07 1990-01-06 1990-07-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-07-07 1994-01-06 1994-07-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-07-07 1998-01-06 1998-07-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag